LPU
OXFD

Lansdowne Partners (UK)’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Lansdowne Partners (UK)’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-722,354
Closed -$7.16M – 65
2016
Q1 		$7.16M Hold
722,354
– – 0.06% 22
2015
Q4 		$8.31M Hold
722,354
– – 0.06% 26
2015
Q3 		$9.75M Hold
722,354
– – 0.08% 20
2015
Q2 		$10M Hold
722,354
– – 0.09% 21
2015
Q1 		$10.2M Buy
722,354
+200,000
+38% +$2.72M 0.09% 24
2014
Q4 		$7.11M Hold
522,354
– – 0.06% 31
2014
Q3 		$7.98M Hold
522,354
– – 0.07% 32
2014
Q2 		$8.79M Buy
+522,354
New +$9.4M 0.08% 31

Other funds holding OXFD

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return